Drug intelligence / Profile preview

very small embryonic-like stem cells

Development stage
Preclinical
Lead developer
University of Louisville
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous, Intralesional
01

Overview

Very small embryonic-like stem cells (VSELs) are a rare population of quiescent, pluripotent stem cells found in adult tissues such as bone marrow, peripheral blood, and umbilical cord blood. Characterized by their exceptionally small size (3–5 μm) and a distinct immunophenotype (typically CD34+/Lin-/CD45- or CD133+/Lin-/CD45-), they express key pluripotency markers including OCT4, SOX2, and NANOG. VSELs are hypothesized to be epiblast-derived cells deposited during early embryogenesis that persist in adult organs to facilitate tissue repair and maintain homeostasis. In regenerative medicine, they are investigated for their ability to home to injured tissues—primarily via the SDF-1/CXCR4 chemotactic axis—and differentiate into various somatic cell types without the ethical concerns or teratoma risks associated with embryonic stem cells. While clinical interest has spanned conditions such as premature ovarian failure, erectile dysfunction, and myocardial repair, several early-phase trials have been withdrawn, and research continues to focus on their ex vivo expansion and role as potential cancer stem cell precursors when dysfunctional.

Other names
VSELvery small embryonic-like cellsautologous very small embryonic-like stem cells

Beyond the preview

Go deeper on very small embryonic-like stem cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on very small embryonic-like stem cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call